Helicobacter pylori Phenotypes Associated with Peptic Ulceration

References

• Blaser M J. Helicobacter pylori: microbiology of a 'slow' bacterial pathogen. Trends Microbiol 1993; 1: 255–60
   PubMedGoogle Scholar
• Blaser M J. Helicobacter pylori and the pathogenesis of gas-troduodenal inflammation. J Infect Dis 1990; 161: 626–33
   PubMed Web of Science ®Google Scholar
• Peterson W L. Helicobacter pylori and peptic ulcer disease. N Engl J Med 1991; 324: 1043–8
   PubMed Web of Science ®Google Scholar
• Asaka M, Kimura T, Kudo M, et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 1992; 102: 760–6
   PubMed Web of Science ®Google Scholar
• Styblo K. Recent advances in epidemiological research in tuberculosis. Adv Tuberc Res 1980; 20: 1–63
   PubMedGoogle Scholar
• Comstock G W, Livesay V T, Woolpert S F. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol 1974; 99: 131–8
   PubMed Web of Science ®Google Scholar
• Sargeaunt P G. The reliability of Entamoeba histolytica zymodemes in clinical diagnosis. Parasitol Today 1987; 3: 40–3
   PubMedGoogle Scholar
• Strachan W E, Spice W M, Chiodini P O, Moody A H, Ackers J P. Immunological differentiation of pathogenic and nonpathogenic isolates of Entamoeba histolytica. Lancet 1988; 1: 561–2
   PubMed Web of Science ®Google Scholar
• Tannich E, Horstmann R D, Knobloch J, Arnold H H. Genomic DNA differences between pathogenic and nonpathogenic Entamoeba histolytica. Proc Natl Acad Sci USA 1989; 86: 5118–22
   PubMed Web of Science ®Google Scholar
• Siegal A C, Johnson E E, Stollerman G H. Controlled studies of streptococcal pharyngitis in a pediatric population. I. Factors related to the attack rate of rheumatic fever. N Engl J Med 1961; 265: 559–66
   Web of Science ®Google Scholar
• Rammelkamp C H, Denny F W, Wannamaker L W. Studies on the epidemiology of rheumatic fever in the armed services. Rheumatic fever: a symposium, L Thomas. University of Minnesota Press, Minneapolis 1952; 72–89
   Google Scholar
• Stollerman G H. The relative rheumatogenicity of strains of group A streptococci. Mod Concepts Cardiovasc Dis 1975; 44: 35–40
   PubMedGoogle Scholar
• Zabriskie J B, Lavencky D, Williams R C, Jr, et al. Rheumatic-fever associated B-cell alloantigens as identified by monoclonal antibodies. Arthritis Rheum 1985; 28: 1047–51
   PubMed Web of Science ®Google Scholar
• Langenberg W, Rauws E A, Widjojokusumo A, Tytgat G NJ, Zanen H C. Identification of Campylobacter pyloridis isolates by restriction endonuclease DNA analysis. J Clin Microbiol 1986; 24: 414–17
   PubMed Web of Science ®Google Scholar
• Akopyanz N, Bukanov N O, Westblom T U, Kresovich S, Berg D E. DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting. Nucleic Acids Res 1992; 20: 5137–42
   PubMed Web of Science ®Google Scholar
• Moran A P, Helander I M, Kosunen T U. Compositional analysis of Helicobacter pylori rough-form lipopolysaccharides. J Bacteriol 1992; 174: 1370–7
   PubMed Web of Science ®Google Scholar
• Mattsby-Baltzer I, Mielniczuk Z, Larsson L, Lindgren K, Goodwin S. Lipid A in Helicobacter pylori. Infect Immun 1992; 60: 4383–7
   PubMed Web of Science ®Google Scholar
• Pérez-Pérez G I, Blaser M J. Conservation and diversity of Campylobacter pyloridis major antigens. Infect Immun 1987; 55: 1256–63
   PubMed Web of Science ®Google Scholar
• Pérez-Pérez G I, Blaser M J, Bryner J. Lipopolysaccharide structures of Campylobacter fetus related to heat-stable serogroups. Infect Immun 1986; 51: 209–12
   PubMed Web of Science ®Google Scholar
• Apel I, Jacobs E, Kist M, Bredt W. Antibody response of patients against a 120 kDa surface protein of Campylobacter pylori. Zentralbl Bakteriol Hyg A 1988; 268: 271–6
   PubMedGoogle Scholar
• Tummuri M KR, Cover T L, Blaser M J. Cloning and expression of a high molecular weight major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun 1993; 61: 1799–809
   PubMed Web of Science ®Google Scholar
• Covacci A, Censini S, Bugnoli M, et al. Molecular characterization of the 128 kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993; 90: 5791–5
   PubMed Web of Science ®Google Scholar
• Cover T L, Dooley C P, Blaser M J. Characterization and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun 1990; 58: 603–10
   PubMed Web of Science ®Google Scholar
• Crabtree J E, Taylor J D, Wyatt J I, et al. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 1991; 338: 332–5
   PubMed Web of Science ®Google Scholar
• Leunk R D. Production of a cytotoxin by Helicobacter pylori. Rev Infect Dis 1991; 13: S686–9
   PubMedGoogle Scholar
• Figura N, Gugliemetti P, Rossolini A, et al. Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. J Clin Microbiol 1989; 27: 225–6
   PubMed Web of Science ®Google Scholar
• Goosens H, Glupczynski Y, Burette A, et al. Role of the vacuolating toxin from Helicobacter pylori in the pathogenesis of duodenal and gastric ulcer. Med Microbiol Lett 1992; 1: 153–9
   Google Scholar
• Cover T L, Cao P, Lind C D, Tham K T, Blaser M J. Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo. Infect Immun 1993; 61: 5008–12
   PubMed Web of Science ®Google Scholar
• Tee W, Lambert J R, Pegorer M, Dwyer B. Cytotoxin production by Helicobacter pylori more common in peptic ulcer disease. Gastroenterology 1993; 104: A789
   PubMed Web of Science ®Google Scholar
• Rautelin H, Blomberg B, Fredlund H, Jarnerot G, Danielsson D. Incidence of Helicobacter pylori strains activating neutrophils in patients with peptic ulcer disease. Gut 1993; 34: 599–604
   PubMed Web of Science ®Google Scholar
• Cover T L, Blaser M J. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem 1992; 267: 10570–5
   PubMed Web of Science ®Google Scholar
• Cover T L, Tummuru M KR, Cao P, Thompson S A, Blaser M J. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem 1994; 269: 10566–73
   PubMed Web of Science ®Google Scholar
• Crabtree J E, Figura N, Taylor J D, Bugnoli M, Armellini D, Tompkins D S. Expression of 120 kilodalton protein and cytotoxicity in Helicobacter pylori. J Clin Pathol 1992; 45: 733–4
   PubMed Web of Science ®Google Scholar
• Owen R J, Bickely J, Moreno M, Costas M, Morgan D R. Biotype and macromolecular profiles of cytotoxin-producing strains of Helicobacter pylori from antral gastric mucosa. FEMS Microbiol Lett 1991; 63: 199–204
   PubMed Web of Science ®Google Scholar
• Shoushia S, Bull T R, Parkins R A. Gastric spiral bacteria. Lancet 1984; 2: 101
   Google Scholar
• Tosi M F, Czinn S J. Opsonic activity of specific human IgG against Helicobacter pylori. J Infect Dis 1990; 162: 156–62
   PubMed Web of Science ®Google Scholar
• Das S S, Karim Q N, Easmon C SF. Opsonophagocytosis of Campylobacter pylori. J Med Microbiol 1988; 27: 125–30
   PubMed Web of Science ®Google Scholar
• Rautelin H, Blomberg B, Jarnerot G, Danielsson D. Non-opsonic activation of neutrophils and cytotoxin production by Helicobacter pylori: ulcerogenic markers. Scand J Gastroenterol 1994; 29: 128–32
   PubMed Web of Science ®Google Scholar